This move is archived. Current quotes and coverage live on the stock page.
Get HBP alerts:
Helix BioPharma Corp. saw its stock price drop sharply, closing down 5.52% in the latest trading session.
Helix BioPharma Corp. (HBP.TO) experienced a significant decline yesterday, closing at CA$1.37. This 5.52% drop raises concerns among investors, especially as the company works to secure financing for its next phase of development.
Advertisement
Helix BioPharma Corp.
HBP.TO
HBP.TO
Helix BioPharma Corp.
WealthAwesomeMarket cap
$145.12M
52W high
$5.40
52W low
$1.10
1W change
-5.00%
Beta
-0.35
Analyst Price Targets
Based on analyst covering HBP
Wall Street analysts forecast HBP stock price to rise 31.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.50
+31.6% Upside
Current Price
C$1.90
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HBP's historical volatility
30-Day Vol
39.4%
Annualized
90-Day Vol
58.2%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$2.27
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$2.02 | C$1.76 โ C$2.31 |
| 60 trading days | C$2.14 | C$1.77 โ C$2.59 |
| 90 trading days | C$2.27 | C$1.79 โ C$2.88 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should be cautious as Helix BioPharma's recent financial disclosures reveal ongoing challenges in securing necessary funding, which could affect its growth.
Stock Down 5.52% in One Day
With a market cap of about CA$110.75 million, Helix BioPharma's stock is under scrutiny as it seeks to stabilize its finances.
Bull case
If Helix BioPharma secures the financing it needs, it could advance its therapeutic programs and potentially reverse the current downward trend.
Bear case
On the other hand, continued financial struggles and difficulty attracting investment could lead to further declines in stock price, especially if the company fails to meet its operational goals.
Recent Performance Overview
Advertisement
In the latest trading session, Helix BioPharma Corp. saw its stock drop by 5.52%, closing at CA$1.37. This decline is concerning, especially given the company's recent announcements about its financial results and the need for additional funding to support operations. Investors are closely monitoring the situation as the company navigates these challenges.
Financial Challenges Ahead
Helix BioPharma has been open about its financial struggles, stressing the need to secure funding to advance its therapeutic programs. The recent announcement about filing interim financial statements hasnโt inspired confidence, leading to a sell-off in shares. Investors should be cautious of the potential for further declines if the company cannot stabilize its finances. For more details on their financial situation, check out the latest filings.
Looking Ahead
As Helix BioPharma Corp. continues to seek funding and address its operational challenges, investors need to weigh the potential for recovery against the risks of further declines. The company's ability to secure necessary capital will be crucial in determining its future performance. For ongoing updates, visit the Helix BioPharma stock page.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
